Brief: Redcare Pharmacy On Track To Meet All Elements Of FY Guidance

Redcare Pharmacy NV

30/07/2024 05:33

July 30 (Reuters) - REDCARE PHARMACY NV  RDC.DE :
    * ADJUSTED. EBITDA OF EUR 27M IN H1 (H1 2023: EUR 22M)
RESULTING
IN A MARGIN OF 2.4%; IN Q2, EUR 15M (H1 2023: EUR 13M) OR A
MARGIN OF 2.7%
    * ON TRACK TO MEET ALL ELEMENTS OF FULL-YEAR GUIDANCE
    * BY THE END OF H1, REDCARE PHARMACY HAD 11.6 MILLION ACTIVE
CUSTOMERS, AN INCREASE OF 1.5 MILLION YEAR OVER YEAR AND 0.4
MILLION IN Q2 ALONE
    * GROUP’S GROSS PROFIT INCREASED FROM EUR 107 MILLION IN Q2
2023
TO EUR 131 MILLION IN Q2 2024
    * IN H1, GROSS PROFIT GREW BY 25% YEAR OVER YEAR TO EUR 262
MILLION (H1 2023: EUR 210 MILLION) WHILE THE GROSS PROFIT MARGIN
WAS 23.4% (H1 2023: 26.5%)

Further company coverage:  RDC.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))